인간면역결핍바이러스(HIV) 진단 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 11.0%로 71억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 공중보건 캠페인 및 인식 제고 활동, 형평성 및 포용성에 대한 강조, 의료 환경에서의 일상적인 검사, 커뮤니티 주도 및 동료 주도 접근 방식, 자가 검사 확대 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 검사 기술의 발전, 표적화된 검사 전략의 중요성, 지역사회 기반 검사 및 아웃리치, 형평성 및 포괄성, 정책 및 자금 우선순위 등이 있습니다.
헌혈의 증가는 당분간 HIV 진단 시장의 성장을 촉진할 것으로 예상됩니다. 헌혈은 채혈을 통한 자발적인 헌혈 행위이지만, 의료 기술의 발전, 지역사회 참여의 증가, 기증자 모집 및 유지 전략 강화 등으로 인해 헌혈이 증가하고 있습니다. 이러한 헌혈의 급격한 증가는 HIV 검사에 사용할 수 있는 샘플 풀을 늘리는 데 도움이 됩니다. 결과적으로 혈액 샘플의 가용성이 높아지면 HIV 항체 또는 항원에 대한 보다 종합적인 검사가 용이해져 HIV 진단의 정확성과 신뢰성이 향상될 수 있습니다. 예를 들어, 영국 정부 기관인 NHS Blood and Transplant는 신규 헌혈자 수가 2022-2023년 11만 9,016명에서 2023-2024년 11만 9,371명으로 증가할 것으로 예상하고 있으며, 이는 헌혈자 수 증가가 HIV 진단 시장 성장에 매우 중요한 역할을 할 것으로 예상하고 있습니다. 중요한 역할을 하고 있음을 뒷받침하고 있습니다.
HIV 진단 시장의 주요 기업들은 정확도 향상, 시간 단축, 접근성 향상을 목표로 HIV에 특화된 칩 기반 실시간 PCR 검사 솔루션을 적극적으로 개발하고 있습니다. 칩 기반 실시간 PCR 검사 솔루션은 미세유체 칩 또는 소형 집적회로를 이용하여 HIV 검출을 위한 실시간 중합효소 연쇄 반응(PCR) 검사를 수행합니다. 예를 들어, 2022년 8월, 인도의 분자진단업체 몰바이오 진단(Molbio Diagnostics)은 전혈 및 혈장 내 인간면역결핍바이러스1형(HIV-1)을 정량적으로 검출하고 진단할 수 있도록 설계된 칩 기반 실시간 PCR 테스트인 Truenat HIV-1 Taqman chemistry를 활용한 이 검사는 높은 프라이머 민감도와 특이성, 최소한의 시료량, 오염 및 증발에 강한 설계 요소와 함께 결과 정량화를 위한 로트별 데이터를 갖춘 지능형 칩을 특징으로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 인간면역결핍바이러스(HIV) 진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 : 성장률 분석
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 실적 : 규모와 성장, 2019-2024
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 인간면역결핍바이러스(HIV) 진단 전체 시장(TAM)
제6장 시장 세분화
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 소모품
- 기기
- 소프트웨어와 서비스
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 : 모드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 셀프 테스트
- 실험실 기반
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 진단 검사실
- 병원
- 조사기관
- 세계의 인간면역결핍바이러스(HIV) 진단 시장, 소모품 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 검사 키트(신속 HIV 검사 키트, ELISA 검사 키트)
- 시약과 화학제품
- 샘플 채취 기구(채혈관, 란셋)
- 테스트 스트립
- 제어 및 교정 키트
- 일회용 장갑과 안전 장비
- 세계의 인간면역결핍바이러스(HIV) 진단 시장, 기기 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- HIV 진단 분석기(자동 면역측정 분석기)
- HIV 바이러스 양검사 장비
- CD4 카운트 분석기
- POC(Point of Care) HIV 진단 장비
- 분자진단 기기(PCR 장비)
- 전기화학적 및 광학적 HIV 검출 장비
- 세계의 인간면역결핍바이러스(HIV) 진단 시장, 소프트웨어 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- HIV 진단 데이터 관리 소프트웨어
- 전자건강기록(EHR) 통합 소프트웨어
- HIV 검사 결과 해석 소프트웨어
- 검사 정보 관리 시스템(LIMS)
- 환자 모니터링 및 추적 소프트웨어
- 클라우드 기반 HIV 진단 보고 툴
- 세계의 인간면역결핍바이러스(HIV) 진단 시장, 서비스 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 진단 검사 서비스
- HIV 검사 지원 서비스(카운셀링, 교육)
- 진단 실험실 서비스
- 원격의료와 원격 HIV 검사 서비스
- HIV 진단 검사 임상시험 서비스
- HIV 검사를 위한 데이터 분석·해석 서비스
제7장 지역별·국가별 분석
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 인간면역결핍바이러스(HIV) 진단 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 인간면역결핍바이러스(HIV) 진단 시장 : 경쟁 구도
- 인간면역결핍바이러스(HIV) 진단 시장 : 기업 개요
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
- Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Hologic Inc.
- bioMerieux SA
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Bio-Techne Corporation
- Alere Inc.
- Cepheid Inc.
- OraSure Technologies Inc.
- Advanced Instruments Inc.
- BBI Solutions
- Chembio Diagnostic Systems Inc.
- BioLytical Laboratories Inc.
- Avioq Inc.
- Advanced Biochemicals Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 인간면역결핍바이러스(HIV) 진단 시장 2029 : 새로운 기회를 제공하는 국가
- 인간면역결핍바이러스(HIV) 진단 시장 2029 : 새로운 기회를 제공하는 부문
- 인간면역결핍바이러스(HIV) 진단 시장 2029 : 성장 전략
제36장 부록
ksm
Human immunodeficiency virus (HIV) diagnosis encompasses the process of determining whether an individual has contracted the human immunodeficiency virus, which leads to acquired immunodeficiency syndrome (AIDS). This diagnostic procedure involves testing for the presence of HIV antibodies, antigens, or viral genetic material in bodily fluids such as blood, saliva, or other relevant specimens.
The primary products utilized in HIV diagnosis include consumables, instruments, and software and services. Consumables refer to materials or supplies that are used up during diagnostic procedures, and they can be deployed in various formats including self-tests and lab-based assays. These products find application across diverse end users such as diagnostic laboratories, hospitals, and research institutions.
The HIV diagnosis market research report is one of a series of new reports from The Business Research Company that provides HIV diagnosis market statistics, including HIV diagnosis industry global market size, regional shares, competitors with a HIV diagnosis market share, detailed HIV diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the HIV diagnosis industry. This HIV diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The human immunodeficiency virus (HIV) diagnosis market size has grown rapidly in recent years. It will grow from $4.2 billion in 2024 to $4.68 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to expansion of voluntary counseling and testing, development of HIV antibody tests, emergence of the HIV/AIDS epidemic, and community-led and peer-led initiatives.
The human immunodeficiency virus (HIV) diagnosis market size is expected to see rapid growth in the next few years. It will grow to $7.12 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to public health campaigns and awareness initiatives, focus on equity and inclusivity, routine testing in healthcare settings, community-led and peer-led approaches, and expansion of self-testing. Major trends in the forecast period include advancements in testing technologies, focus on targeted testing strategies, community-based testing and outreach, emphasis on equity and inclusivity, and policy and funding priorities.
The anticipated increase in blood donation is poised to drive the expansion of the HIV diagnosis market in the foreseeable future. Blood donation, characterized by the voluntary act of giving blood through phlebotomy, has seen a rise attributed to advancements in medical technology, heightened community engagement, and enhanced donor recruitment and retention strategies. This surge in blood donation results in a larger pool of samples available for HIV testing. Consequently, the heightened availability of blood samples facilitates more comprehensive screening for HIV antibodies or antigens, thereby improving the accuracy and reliability of HIV diagnosis. For example, NHS Blood and Transplant, a UK-based government agency, reported an increase in new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024, underscoring the pivotal role of rising blood donation in propelling the growth of the HIV diagnosis market.
Major players in the HIV diagnosis market are actively developing chip-based real-time PCR test solutions tailored for HIV, aimed at enhancing accuracy, reducing turnaround time, and improving accessibility. Chip-based real-time PCR test solutions utilize microfluidic chips or small integrated circuits to conduct real-time polymerase chain reaction (PCR) tests for HIV detection. For instance, in August 2022, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, unveiled the Truenat HIV-1 test, a chip-based real-time PCR test designed for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma. Leveraging Taqman chemistry, this test boasts high primer sensitivity and specificity, requiring minimal sample volume and featuring an intelligent chip with lot-specific data for result quantification, along with contamination- and evaporation-resistant design elements.
In May 2022, Roche, a Switzerland-based biopharmaceutical and diagnostic company, forged a partnership with the Global Fund, aiming to bolster diagnostic infrastructure in low- and middle-income countries. This collaboration seeks to facilitate improved diagnosis and treatment of HIV and tuberculosis within the framework of Roche's Global Access Program and the Global Fund's broader initiatives targeting HIV, tuberculosis, and malaria globally. The Global Fund, an international financing and partnership organization headquartered in Switzerland, focuses on providing grants to strengthen health systems addressing HIV/AIDS.
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Becton Dickinson and Company, Hologic Inc., bioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc., OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.
North America was the largest region in the HIV diagnosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the human immunodeficiency virus (HIV) diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The human immunodeficiency virus (HIV) diagnosis market consists of revenues earned by entities by providing services such as HIV testing, pre-test counseling, post-test counseling, laboratory-based testing, point-of-care testing, partner notification services, and linkage to care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human immunodeficiency virus (HIV) diagnosis market also includes sales of diagnostic kits, testing equipment such as enzyme-linked immunosorbent assay (ELISA) readers and polymerase chain reaction (PCR) machines, point-of-care testing devices, laboratory equipment such as centrifuges and microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on human immunodeficiency virus (hiv) diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for human immunodeficiency virus (hiv) diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human immunodeficiency virus (hiv) diagnosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Consumables; Instruments; Software And Services
- 2) By Mode: Self-Test; Lab-Based
- 3) By End User: Diagnostic Laboratories; Hospitals; Research Institutions
- Subsegments:
- 1) By Consumables: Test Kits (Rapid Hiv Test Kits, Elisa Test Kits); Reagents And Chemicals; Sample Collection Devices (Blood Collection Tubes, Lancets); Test Strips; Control And Calibration Kits; Disposable Gloves And Safety Equipment
- 2) By Instruments: Hiv Diagnostic Analyzers ( Automated Immunoassay Analyzers); Hiv Viral Load Testing Equipment; Cd4 Count Analyzers; Point-Of-Care Hiv Diagnostic Devices; Molecular Diagnostic Instruments ( Pcr Machines); Electrochemical And Optical Hiv Detection Instruments
- 3) By Software: Hiv Diagnosis Data Management Software; Electronic Health Record (Ehr) Integration Software; Hiv Test Result Interpretation Software; Laboratory Information Management Systems (Lims); Patient Monitoring And Tracking Software; Cloud-Based Hiv Diagnostic Reporting Tools
- 4) By Services: Diagnostic Testing Services; Hiv Testing Support Services ( Counseling, Education); Diagnostic Lab Services; Telemedicine And Remote Hiv Testing Services; Clinical Trial Services For Hiv Diagnostic Tests; Data Analytics And Interpretation Services For Hiv Testing
- Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers; Roche Diagnostics; Becton Dickinson and Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Human Immunodeficiency Virus (HIV) Diagnosis Market Characteristics
3. Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies
4. Human Immunodeficiency Virus (HIV) Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Human Immunodeficiency Virus (HIV) Diagnosis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Human Immunodeficiency Virus (HIV) Diagnosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Growth Rate Analysis
- 5.4. Global Human Immunodeficiency Virus (HIV) Diagnosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Human Immunodeficiency Virus (HIV) Diagnosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Human Immunodeficiency Virus (HIV) Diagnosis Total Addressable Market (TAM)
6. Human Immunodeficiency Virus (HIV) Diagnosis Market Segmentation
- 6.1. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Consumables
- Instruments
- Software And Services
- 6.2. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Self-Test
- Lab-Based
- 6.3. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Laboratories
- Hospitals
- Research Institutions
- 6.4. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Test Kits (Rapid HIV Test Kits, ELISA Test Kits)
- Reagents And Chemicals
- Sample Collection Devices (Blood Collection Tubes, Lancets)
- Test Strips
- Control And Calibration Kits
- Disposable Gloves And Safety Equipment
- 6.5. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- HIV Diagnostic Analyzers (Automated Immunoassay Analyzers)
- HIV Viral Load Testing Equipment
- CD4 Count Analyzers
- Point-Of-Care HIV Diagnostic Devices
- Molecular Diagnostic Instruments (PCR Machines)
- Electrochemical And Optical HIV Detection Instruments
- 6.6. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- HIV Diagnosis Data Management Software
- Electronic Health Record (EHR) Integration Software
- HIV Test Result Interpretation Software
- Laboratory Information Management Systems (LIMS)
- Patient Monitoring And Tracking Software
- Cloud-Based HIV Diagnostic Reporting Tools
- 6.7. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Testing Services
- HIV Testing Support Services (Counseling, Education)
- Diagnostic Lab Services
- Telemedicine And Remote HIV Testing Services
- Clinical Trial Services For HIV Diagnostic Tests
- Data Analytics And Interpretation Services For HIV Testing
7. Human Immunodeficiency Virus (HIV) Diagnosis Market Regional And Country Analysis
- 7.1. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Human Immunodeficiency Virus (HIV) Diagnosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market
- 8.1. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Human Immunodeficiency Virus (HIV) Diagnosis Market
- 9.1. China Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 9.2. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Human Immunodeficiency Virus (HIV) Diagnosis Market
- 10.1. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market
- 11.1. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 11.2. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market
- 12.1. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market
- 13.1. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market
- 14.1. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 14.2. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market
- 15.1. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 15.2. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Human Immunodeficiency Virus (HIV) Diagnosis Market
- 16.1. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market
- 17.1. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Human Immunodeficiency Virus (HIV) Diagnosis Market
- 18.1. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market
- 19.1. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market
- 20.1. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market
- 21.1. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 21.2. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market
- 22.1. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Human Immunodeficiency Virus (HIV) Diagnosis Market
- 23.1. North America Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 23.2. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Human Immunodeficiency Virus (HIV) Diagnosis Market
- 24.1. USA Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 24.2. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market
- 25.1. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 25.2. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Human Immunodeficiency Virus (HIV) Diagnosis Market
- 26.1. South America Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 26.2. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market
- 27.1. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market
- 28.1. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 28.2. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market
- 29.1. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market Overview
- 29.2. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Human Immunodeficiency Virus (HIV) Diagnosis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Landscape And Company Profiles
- 30.1. Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Landscape
- 30.2. Human Immunodeficiency Virus (HIV) Diagnosis Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
31. Human Immunodeficiency Virus (HIV) Diagnosis Market Other Major And Innovative Companies
- 31.1. Hologic Inc.
- 31.2. bioMerieux SA
- 31.3. Beckman Coulter Inc.
- 31.4. Bio-Rad Laboratories Inc.
- 31.5. QIAGEN N.V.
- 31.6. Bio-Techne Corporation
- 31.7. Alere Inc.
- 31.8. Cepheid Inc.
- 31.9. OraSure Technologies Inc.
- 31.10. Advanced Instruments Inc.
- 31.11. BBI Solutions
- 31.12. Chembio Diagnostic Systems Inc.
- 31.13. BioLytical Laboratories Inc.
- 31.14. Avioq Inc.
- 31.15. Advanced Biochemicals Ltd.
32. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Human Immunodeficiency Virus (HIV) Diagnosis Market
34. Recent Developments In The Human Immunodeficiency Virus (HIV) Diagnosis Market
35. Human Immunodeficiency Virus (HIV) Diagnosis Market High Potential Countries, Segments and Strategies
- 35.1 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Human Immunodeficiency Virus (HIV) Diagnosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
